Perry, who long defended the vaccine mandate, reversed his position on the issue as he launched his GOP presidential bid, calling the order “a mistake” and saying he agrees with the Texas legislature’s decision to overturn it.
“The fact of the matter is that I didn’t do my research well enough to understand that we needed to have a substantial conversation with our citizenry,” Perry told reporters on the campaign trail in August.
Perry reiterated his belief that he made a mistake by issuing the executive order, which allowed parents to opt out.
“If I had it to do over again, I would have done it differently.” The episode illustrates the difficulties Perry faces in navigating competing Republican interest groups, and it resurrects allegations of cronyism that have dogged the Texas executive throughout his political career.
Over a 4- to 5-year period of observation, they have been nearly 100 percent effective in preventing incident persistent infections and cervical intra-epithelial neoplasia by HPV types in the vaccine.
Gardasil is designed to protect against infections with four of about 40 genital tract HPVs, types 16, 18, 6, and 11.
HPV 16 and HPV 18 are responsible for about 70 percent of invasive cervical cancers and for a larger majority of the HPV-related cancers at other sites [1,2].
The recognition that invasive carcinoma of the uterine cervix is the end result of some genital tract human papillomavirus (HPV) infections and the development of prophylactic vaccines to prevent these infections are major recent achievements of public health medicine.
The quadrivalent Gardasil HPV vaccine from Merck & Co., Inc., was licensed by the Food and Drug Administration (FDA) in June 2006 and was subsequently recommended by the Advisory Council on Immunization Practices (ACIP) for vaccination of adolescent girls and young women.